Joint Filing Agreement
Exhibit 99.1
Each of the undersigned hereby expresses its agreement that the attached Schedule 13D (and any amendments thereto) relating to the Common Stock of Tokai Pharmaceuticals, Inc. is filed on behalf of each of the undersigned.
| Date: October 1, 2014 | NOVARTIS BIOVENTURES LTD. | |||||
| By: | /s/ Xxxxxxx Xxxxx | |||||
| Name: | Xxxxxxx Xxxxx | |||||
| Title: | Director | |||||
| By: | /s/ Xxxxxxxxx Xxxxxxxxxx | |||||
| Name: | Xxxxxxxxx Xxxxxxxxxx | |||||
| Title: | Authorised Signatory | |||||
| NOVARTIS AG | ||||||
| By: | /s/ Xxxxxxx Xxxxx | |||||
| Name: | Xxxxxxx Xxxxx | |||||
| Title: | Authorised Signatory | |||||
| By: | /s/ Xxxxx Xxxxxxxxx | |||||
| Name: | Xxxxx Xxxxxxxxx | |||||
| Title: | Authorised Signatory | |||||
